Core Scientific Statistics
Total Valuation
Core Scientific has a market cap or net worth of $2.20 billion. The enterprise value is $2.56 billion.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Core Scientific has 294.12 million shares outstanding. The number of shares has decreased by -32.65% in one year.
| Current Share Class | 294.12M |
| Shares Outstanding | 294.12M |
| Shares Change (YoY) | -32.65% |
| Shares Change (QoQ) | +4.67% |
| Owned by Insiders (%) | 6.30% |
| Owned by Institutions (%) | 77.85% |
| Float | 252.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.16 |
| PS Ratio | 3.75 |
| Forward PS | 3.67 |
| PB Ratio | -2.68 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 51.29 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.02 |
| EV / EBITDA | 26.10 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.72
| Current Ratio | 6.72 |
| Quick Ratio | 6.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | 10.62 |
| Debt / FCF | n/a |
| Interest Coverage | -0.40 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -0.81% |
| Return on Invested Capital (ROIC) | -2.71% |
| Return on Capital Employed (ROCE) | -1.02% |
| Revenue Per Employee | $1.57M |
| Profits Per Employee | -$3.45M |
| Employee Count | 325 |
| Asset Turnover | 0.44 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Core Scientific has paid $859,000 in taxes.
| Income Tax | 859,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +121.96% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +121.96% |
| 50-Day Moving Average | 10.93 |
| 200-Day Moving Average | 12.03 |
| Relative Strength Index (RSI) | 35.48 |
| Average Volume (20 Days) | 22,692,306 |
Short Selling Information
The latest short interest is 42.95 million, so 14.60% of the outstanding shares have been sold short.
| Short Interest | 42.95M |
| Short Previous Month | 42.01M |
| Short % of Shares Out | 14.60% |
| Short % of Float | 17.04% |
| Short Ratio (days to cover) | 2.02 |
Income Statement
In the last 12 months, Core Scientific had revenue of $510.67 million and -$1.12 billion in losses. Loss per share was -$4.39.
| Revenue | 510.67M |
| Gross Profit | 133.30M |
| Operating Income | -14.99M |
| Pretax Income | -830.24M |
| Net Income | -1.12B |
| EBITDA | 98.22M |
| EBIT | -14.99M |
| Loss Per Share | -$4.39 |
Full Income StatementBalance Sheet
The company has $836.20 million in cash and $1.20 billion in debt, giving a net cash position of -$363.57 million or -$1.24 per share.
| Cash & Cash Equivalents | 836.20M |
| Total Debt | 1.20B |
| Net Cash | -363.57M |
| Net Cash Per Share | -$1.24 |
| Equity (Book Value) | -820.18M |
| Book Value Per Share | -2.80 |
| Working Capital | 769.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $42.90 million and capital expenditures -$94.96 million, giving a free cash flow of -$52.07 million.
| Operating Cash Flow | 42.90M |
| Capital Expenditures | -94.96M |
| Free Cash Flow | -52.07M |
| FCF Per Share | -$0.18 |
Full Cash Flow StatementMargins
Gross margin is 26.10%, with operating and profit margins of -2.93% and -257.50%.
| Gross Margin | 26.10% |
| Operating Margin | -2.93% |
| Pretax Margin | -257.34% |
| Profit Margin | -257.50% |
| EBITDA Margin | 19.23% |
| EBIT Margin | -2.93% |
| FCF Margin | n/a |
Dividends & Yields
Core Scientific does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 32.65% |
| Shareholder Yield | n/a |
| Earnings Yield | -51.02% |
| FCF Yield | -2.37% |
Analyst Forecast
The average price target for Core Scientific is $19.14, which is 155.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.14 |
| Price Target Difference | 155.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 31.13% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Core Scientific has an Altman Z-Score of -1.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.89 |
| Piotroski F-Score | 4 |